Company news
Forte Biosciences, Inc. news in 2026
Forte Biosciences, Inc.'s news releases, calls and decks from 2026, newest first.
FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
July 9, 2026
Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update
May 11, 2026
Forte Biosciences Announces Pricing of $150 Million Public Offering
April 7, 2026
Forte Biosciences, Inc. Announces 2025 Results and Provides Update
March 30, 2026
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
March 3, 2026
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 9, 2026